Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 26

1.

Human and Extracellular DNA Depletion for Metagenomic Analysis of Complex Clinical Infection Samples Yields Optimized Viable Microbiome Profiles.

Nelson MT, Pope CE, Marsh RL, Wolter DJ, Weiss EJ, Hager KR, Vo AT, Brittnacher MJ, Radey MC, Hayden HS, Eng A, Miller SI, Borenstein E, Hoffman LR.

Cell Rep. 2019 Feb 19;26(8):2227-2240.e5. doi: 10.1016/j.celrep.2019.01.091.

2.

Restoring Cystic Fibrosis Transmembrane Conductance Regulator Function Reduces Airway Bacteria and Inflammation in People with Cystic Fibrosis and Chronic Lung Infections.

Hisert KB, Heltshe SL, Pope C, Jorth P, Wu X, Edwards RM, Radey M, Accurso FJ, Wolter DJ, Cooke G, Adam RJ, Carter S, Grogan B, Launspach JL, Donnelly SC, Gallagher CG, Bruce JE, Stoltz DA, Welsh MJ, Hoffman LR, McKone EF, Singh PK.

Am J Respir Crit Care Med. 2017 Jun 15;195(12):1617-1628. doi: 10.1164/rccm.201609-1954OC.

3.

LasR Variant Cystic Fibrosis Isolates Reveal an Adaptable Quorum-Sensing Hierarchy in Pseudomonas aeruginosa.

Feltner JB, Wolter DJ, Pope CE, Groleau MC, Smalley NE, Greenberg EP, Mayer-Hamblett N, Burns J, Déziel E, Hoffman LR, Dandekar AA.

MBio. 2016 Oct 4;7(5). pii: e01513-16. doi: 10.1128/mBio.01513-16.

4.

Staphylococcus aureus Protein A Mediates Interspecies Interactions at the Cell Surface of Pseudomonas aeruginosa.

Armbruster CR, Wolter DJ, Mishra M, Hayden HS, Radey MC, Merrihew G, MacCoss MJ, Burns J, Wozniak DJ, Parsek MR, Hoffman LR.

MBio. 2016 May 24;7(3). pii: e00538-16. doi: 10.1128/mBio.00538-16.

5.

Optimized In Vitro Antibiotic Susceptibility Testing Method for Small-Colony Variant Staphylococcus aureus.

Precit MR, Wolter DJ, Griffith A, Emerson J, Burns JL, Hoffman LR.

Antimicrob Agents Chemother. 2016 Jan 4;60(3):1725-35. doi: 10.1128/AAC.02330-15.

6.

Strength in diversity.

Wolter DJ, Hoffman LR.

Cell Host Microbe. 2014 Oct 8;16(4):427-9. doi: 10.1016/j.chom.2014.09.018.

7.

Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Mayer-Hamblett N, Rosenfeld M, Gibson RL, Ramsey BW, Kulasekara HD, Retsch-Bogart GZ, Morgan W, Wolter DJ, Pope CE, Houston LS, Kulasekara BR, Khan U, Burns JL, Miller SI, Hoffman LR.

Am J Respir Crit Care Med. 2014 Aug 1;190(3):289-97. doi: 10.1164/rccm.201404-0681OC.

8.

Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.

Mayer-Hamblett N, Ramsey BW, Kulasekara HD, Wolter DJ, Houston LS, Pope CE, Kulasekara BR, Armbruster CR, Burns JL, Retsch-Bogart G, Rosenfeld M, Gibson RL, Miller SI, Khan U, Hoffman LR.

Clin Infect Dis. 2014 Sep 1;59(5):624-31. doi: 10.1093/cid/ciu385. Epub 2014 May 26.

9.

Pediatric infection and intestinal carriage due to extended-spectrum-cephalosporin-resistant Enterobacteriaceae.

Zerr DM, Qin X, Oron AP, Adler AL, Wolter DJ, Berry JE, Hoffman L, Weissman SJ.

Antimicrob Agents Chemother. 2014 Jul;58(7):3997-4004. doi: 10.1128/AAC.02558-14. Epub 2014 May 5.

10.

Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis.

Wolter DJ, Emerson JC, McNamara S, Buccat AM, Qin X, Cochrane E, Houston LS, Rogers GB, Marsh P, Prehar K, Pope CE, Blackledge M, Déziel E, Bruce KD, Ramsey BW, Gibson RL, Burns JL, Hoffman LR.

Clin Infect Dis. 2013 Aug;57(3):384-91. doi: 10.1093/cid/cit270. Epub 2013 Apr 26.

11.

Mechanisms of β-lactam resistance among Pseudomonas aeruginosa.

Wolter DJ, Lister PD.

Curr Pharm Des. 2013;19(2):209-22. Review.

PMID:
22894618
12.

Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms.

Lister PD, Wolter DJ, Hanson ND.

Clin Microbiol Rev. 2009 Oct;22(4):582-610. doi: 10.1128/CMR.00040-09. Review.

13.

Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.

Wolter DJ, Black JA, Lister PD, Hanson ND.

J Antimicrob Chemother. 2009 Aug;64(2):294-300. doi: 10.1093/jac/dkp185. Epub 2009 May 25.

PMID:
19468029
14.

Surveillance of carbapenem-resistant Pseudomonas aeruginosa isolates from Puerto Rican Medical Center Hospitals: dissemination of KPC and IMP-18 beta-lactamases.

Wolter DJ, Khalaf N, Robledo IE, Vázquez GJ, Santé MI, Aquino EE, Goering RV, Hanson ND.

Antimicrob Agents Chemother. 2009 Apr;53(4):1660-4. doi: 10.1128/AAC.01172-08. Epub 2009 Feb 2.

15.

Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4.

Wolter DJ, Kurpiel PM, Woodford N, Palepou MF, Goering RV, Hanson ND.

Antimicrob Agents Chemother. 2009 Feb;53(2):557-62. doi: 10.1128/AAC.00734-08. Epub 2008 Nov 17.

16.

Isolation and characterization of an epidemic methicillin-resistant Staphylococcus aureus 15 variant in the central United States.

Wolter DJ, Chatterjee A, Varman M, Goering RV.

J Clin Microbiol. 2008 Oct;46(10):3548-9. doi: 10.1128/JCM.00985-08. Epub 2008 Jul 30. No abstract available.

17.

Emergence of carbapenem resistance in Pseudomonas aeruginosa isolates from a patient with cystic fibrosis in the absence of carbapenem therapy.

Wolter DJ, Acquazzino D, Goering RV, Sammut P, Khalaf N, Hanson ND.

Clin Infect Dis. 2008 Jun 15;46(12):e137-41. doi: 10.1086/588484.

PMID:
18462098
18.

Allelic variation in genes encoding Panton-Valentine leukocidin from community-associated Staphylococcus aureus.

Wolter DJ, Tenover FC, Goering RV.

Clin Microbiol Infect. 2007 Aug;13(8):827-30.

19.

Increased expression of ampC in Pseudomonas aeruginosa mutants selected with ciprofloxacin.

Wolter DJ, Schmidtke AJ, Hanson ND, Lister PD.

Antimicrob Agents Chemother. 2007 Aug;51(8):2997-3000. Epub 2007 May 21.

20.

Epidemiologic distribution of the arginine catabolic mobile element among selected methicillin-resistant and methicillin-susceptible Staphylococcus aureus isolates.

Goering RV, McDougal LK, Fosheim GE, Bonnstetter KK, Wolter DJ, Tenover FC.

J Clin Microbiol. 2007 Jun;45(6):1981-4. Epub 2007 Apr 4.

21.

Rapid multiplex PCR assay for identification of USA300 community-associated methicillin-resistant Staphylococcus aureus isolates.

Bonnstetter KK, Wolter DJ, Tenover FC, McDougal LK, Goering RV.

J Clin Microbiol. 2007 Jan;45(1):141-6. Epub 2006 Nov 8.

22.

Levofloxacin/imipenem prevents the emergence of high-level resistance among Pseudomonas aeruginosa strains already lacking susceptibility to one or both drugs.

Lister PD, Wolter DJ, Wickman PA, Reisbig MD.

J Antimicrob Chemother. 2006 May;57(5):999-1003. Epub 2006 Mar 2.

PMID:
16513915
24.
25.

Multidrug resistance associated with mexXY expression in clinical isolates of Pseudomonas aeruginosa from a Texas hospital.

Wolter DJ, Smith-Moland E, Goering RV, Hanson ND, Lister PD.

Diagn Microbiol Infect Dis. 2004 Sep;50(1):43-50.

PMID:
15380277
26.

Insertional inactivation of oprD in clinical isolates of Pseudomonas aeruginosa leading to carbapenem resistance.

Wolter DJ, Hanson ND, Lister PD.

FEMS Microbiol Lett. 2004 Jul 1;236(1):137-43.

Supplemental Content

Loading ...
Support Center